Literature DB >> 26063666

What Is the Role of the Adipocyte Mineralocorticoid Receptor in the Metabolic Syndrome?

Celso E Gomez-Sanchez1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26063666      PMCID： PMC5488259          DOI： 10.1161/HYPERTENSIONAHA.115.05148

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  10 in total

1.  Pivotal role of the mineralocorticoid receptor in corticosteroid-induced adipogenesis.

Authors:  Massimiliano Caprio; Bruno Fève; Aurélie Claës; Say Viengchareun; Marc Lombès; Maria-Christina Zennaro
Journal:  FASEB J       Date:  2007-03-23       Impact factor: 5.191

2.  The role of aldosteronism in causing obesity-related cardiovascular risk.

Authors:  David A Calhoun; Kumar Sharma
Journal:  Cardiol Clin       Date:  2010-08       Impact factor: 2.213

3.  Adipocyte Mineralocorticoid Receptor Activation Leads to Metabolic Syndrome and Induction of Prostaglandin D2 Synthase.

Authors:  Riccardo Urbanet; Aurelie Nguyen Dinh Cat; Alessandra Feraco; Nicolas Venteclef; Soumaya El Mogrhabi; Catalina Sierra-Ramos; Diego Alvarez de la Rosa; Gail K Adler; Didier Quilliot; Patrick Rossignol; Francesco Fallo; Rhian M Touyz; Frédéric Jaisser
Journal:  Hypertension       Date:  2015-05-11       Impact factor: 10.190

4.  Adipocytes produce aldosterone through calcineurin-dependent signaling pathways: implications in diabetes mellitus-associated obesity and vascular dysfunction.

Authors:  Ana M Briones; Aurelie Nguyen Dinh Cat; Glaucia E Callera; Alvaro Yogi; Dylan Burger; Ying He; Jose W Corrêa; Anne Marie Gagnon; Celso E Gomez-Sanchez; Elise P Gomez-Sanchez; Alexander Sorisky; Teik Chye Ooi; Marcel Ruzicka; Kevin D Burns; Rhian M Touyz
Journal:  Hypertension       Date:  2012-04-09       Impact factor: 10.190

Review 5.  Mineralocorticoid receptor in adipocytes and macrophages: a promising target to fight metabolic syndrome.

Authors:  Vincenzo Marzolla; Andrea Armani; Alessandra Feraco; Massimo U De Martino; Andrea Fabbri; Giuseppe Rosano; Massimiliano Caprio
Journal:  Steroids       Date:  2014-05-10       Impact factor: 2.668

6.  The lipocalin-type prostaglandin D2 synthase knockout mouse model of insulin resistance and obesity demonstrates early hypothalamic-pituitary-adrenal axis hyperactivity.

Authors:  Jodi F Evans; Shahidul Islam; Yoshihiro Urade; Naomi Eguchi; Louis Ragolia
Journal:  J Endocrinol       Date:  2013-01-18       Impact factor: 4.286

7.  The balance between gluco- and mineralo-corticoid action critically determines inflammatory adipocyte responses.

Authors:  J Hoppmann; N Perwitz; B Meier; M Fasshauer; D Hadaschik; H Lehnert; J Klein
Journal:  J Endocrinol       Date:  2009-11-25       Impact factor: 4.286

Review 8.  Obesity and corticosteroids: 11beta-hydroxysteroid type 1 as a cause and therapeutic target in metabolic disease.

Authors:  Nicholas Michael Morton
Journal:  Mol Cell Endocrinol       Date:  2009-10-03       Impact factor: 4.102

9.  Paradoxical resistance to high-fat diet-induced obesity and altered macrophage polarization in mineralocorticoid receptor-overexpressing mice.

Authors:  Emmanuelle Kuhn; Christine Bourgeois; Vixra Keo; Say Viengchareun; Adeline Muscat; Geri Meduri; Damien Le Menuet; Bruno Fève; Marc Lombès
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-11-12       Impact factor: 4.310

10.  The glucocorticoid receptor, not the mineralocorticoid receptor, plays the dominant role in adipogenesis and adipokine production in human adipocytes.

Authors:  M-J Lee; S K Fried
Journal:  Int J Obes (Lond)       Date:  2014-01-16       Impact factor: 5.095
  10 in total
  2 in total

Review 1.  Aldosterone Production and Signaling Dysregulation in Obesity.

Authors:  Andrea Vecchiola; Carlos F Lagos; Cristian A Carvajal; Rene Baudrand; Carlos E Fardella
Journal:  Curr Hypertens Rep       Date:  2016-03       Impact factor: 5.369

Review 2.  Role of Mineralocorticoid Receptors in Obstructive Sleep Apnea and Metabolic Syndrome.

Authors:  Badhma Valaiyapathi; David A Calhoun
Journal:  Curr Hypertens Rep       Date:  2018-03-19       Impact factor: 5.369
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.